STUDY OBJECTIVE

OSJ ℞ will provide partner clinicians with an allocation of BRAZIER^TM MDI-P prototype kits and supporting materials. The clinicians would prescribe the MDI-P to their patients, to initiate, maintain and adjust their botanical cannabis medicaments. The end goal is for patients to effectually use our standardized system and method to microdose their prescribed medical cannabis flower, to ensure they receive the same formulation and dose each time for greater control of their treatment. 

As a strain-agnostic system and method, the BRAZIER^TM MDI-P will allow clinicians to target specific terpene and minor cannabinoid profiles across different cannabis strains for targeted symptom relief.